Biosyent's total assets for Q1 2025 were C$42.76M, an increase of 3.39% from the previous quarter. TSE:RX total liabilities were C$6.75M for the fiscal quarter, a 6.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.